Efficacy of ciprofloxacin in the eradication of Helicobacter pylori

Southern Medical Journal

Volumn 89, Issue 8, 1996, Pages 775-778

  Dresner, David ^a   Coyle, Walter ^a   Nemec, Richard ^a   Peterson, Richard ^a   Duntemann, Thomas ^a   Lawson, J Mark ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH; CIPROFLOXACIN; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL; STOMACH PH;

EID: 0029819942     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199608000-00004     Document Type: Article

References (24)

1. Graham DY, Lew GM, Klein PD, et al: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116:705-708
2. Hentschel E, Brandstatter G, Dragosics B, et al: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328:308-312
3. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-69
4. Peterson WL: Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324:1043-1048
5. de Boer WA, Driessen WM, Potters VP, et al: Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89:1993-1997
6. Chiba N, Rao BV, Rademaker JW, et al: Meta-analysis of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 12:1716-1727
7. Westblom TU, Unge P: Drug resistance of Helicobacter pylori: memorandum from a meeting at the Sixth International Workshop on Campylobacter, Helicobacter, and Related Organisms. J Infect Dis 1992; 165:974-975
8. Marshall BJ: Treatment strategies for Helicobacter pylori infection. Gastroenterol Clin North Am 1993; 22:183-198
9. Bayerdorffer E, Ottenjann R: The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol 1988; 142(suppl):93-100
10. Hirschl AM, Hentschel E, Schutze K, et al: The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 1988; 142(suppl):76-81
11. Simor AE, Ferro S, Low DE: Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. J Antimicrob Chemother 1989; 33:108-109
12. Andreasen JJ, Andersen LP: In vitro susceptibility of Campylobacter pylori to cimetidine, sucralfate, bismuth and sixteen antibiotics. Acta Pathol Microbiol Immunol Scand 1987; 95:147-149
13. Stone JW, Wise R, Donovan IA, et al: Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach. J Antimicrob Chemother 1988; 22:92-93
14. Forsmark CE, Wilcox CM, Cello JP, et al: Ciprofloxacin in the treatment of Helicobacter pylori in patients with gastritis and peptic ulcer. J Infect Dis 1990; 162:998-999
15. McNulty CAM, Dent JC, Ford GA, et al: Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22:729-738
16. Bayerdorffer E, Kasper G, Sommer A, et al: Abstract 13, Fourth International Workshop on Campylobacter Infections, Göteburg, Sweden, June 16-18, 1987
17. Frost RW, Lasseter KC, Noe AJ, et al: Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother 1992; 36:830-832
18. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 1994; 89(suppl):116-128
19. Tytgat GNJ, Axon ATR, Dixon MF, et al: Helicobacter pylori: causal agent in peptic ulcer? Working Party Reports of the World Congresses of Gastroenterology. Melbourne, Australia, Blackwell Scientific Publications, 1990, pp 3645
20. Glupczynski Y, Labbe M, Burette A, et al: Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet 1987; 1:1096
21. Westblom TU, Duriex DE: Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist: implications for treatment of Helicobacter pylori infections. Dig Dis Sci 1991; 36:25-28
22. Graham DY, Lew GM, Malaty HM, et al: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102:493-496
23. Borody TJ, Cole P, Noonan S, et al: Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151:431-435
24. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335:1233-1235